Privia Health Group, Inc. - COMMON STOCK (PRVA)

Historical Holders from Q2 2021 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
PRVA on Nasdaq
Shares outstanding
122,421,097
Price per share
$23.71
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
119,699,630
Total reported value
$2,980,447,755
% of total 13F portfolios
0%
Share change
+2,112,124
Value change
+$56,454,820
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
253
Price from insider filings
$25.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Privia Health Group, Inc. - COMMON STOCK (PRVA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $354,852,699 15,394,911 BlackRock, Inc. 31 Mar 2025
FMR LLC 10% -12% $307,876,816 -$37,008,945 12,364,531 -11% FMR LLC 30 Sep 2025
Boehler Adam 4.7% -8.8% $143,760,698 -$12,574,500 5,773,522 -8% Puma Growth Holdings, LLC 20 Oct 2025
As of 30 Sep 2025, Privia Health Group, Inc. - COMMON STOCK (PRVA) has 253 institutional shareholders filing 13F forms. They hold 119,699,630 shares. of 122,421,097 outstanding shares (98%) .

Top 25 institutional shareholders own 83% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 19,526,145 +4.2% 0.01% $486,201,011
FMR LLC 10% 12,464,531 -11% 0.02% $310,366,817
VANGUARD GROUP INC 9.9% 12,098,933 +5.3% 0% $301,263,431
Durable Capital Partners LP 9.6% 11,691,685 +1.8% 2.2% $291,122,957
Rubicon Founders LLC 4.7% 5,773,522 0% 75% $143,760,698
RIVERBRIDGE PARTNERS LLC 3.8% 4,633,867 -6.3% 1.9% $115,383,300
STATE STREET CORP 3.6% 4,353,218 +4.4% 0% $108,395,128
Van Berkom & Associates Inc. 3.1% 3,774,565 +30% 2.7% $93,987,000
Bank of New York Mellon Corp 2.5% 3,073,481 +43% 0.01% $76,529,674
GEODE CAPITAL MANAGEMENT, LLC 2.3% 2,783,086 +4.8% 0% $69,309,732
PRINCIPAL FINANCIAL GROUP INC 2.2% 2,744,213 -2.2% 0.03% $68,330,903
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.8% 2,165,355 +2.7% 0.01% $53,917,340
DIMENSIONAL FUND ADVISORS LP 1.7% 2,135,623 +11% 0.01% $53,172,248
FRANKLIN RESOURCES INC 1.3% 1,596,634 +19% 0.01% $39,756,184
NORTHERN TRUST CORP 1.1% 1,374,027 -1.9% 0% $34,213,273
Point72 Asset Management, L.P. 1.1% 1,295,339 0.07% $32,253,932
BANK OF AMERICA CORP /DE/ 1% 1,280,284 +5.9% 0% $31,879,071
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 1,277,386 +5.9% 0.01% $31,806,911
SILVERCREST ASSET MANAGEMENT GROUP LLC 1% 1,259,911 +1.1% 0.21% $31,371,784
Nuveen, LLC 0.97% 1,192,318 -16% 0.01% $29,688,718
LOOMIS SAYLES & CO L P 0.93% 1,134,065 -3.7% 0.03% $28,238,218
BlackBarn Capital Partners LP 0.89% 1,090,382 +45% 8.9% $27,150,512
MORGAN STANLEY 0.8% 982,621 -11% 0% $24,467,283
Freestone Grove Partners LP 0.71% 863,148 +60% 0.16% $21,492,385
EVENTIDE ASSET MANAGEMENT, LLC 0.6% 737,694 -10% 0.3% $18,368,581

Institutional Holders of Privia Health Group, Inc. - COMMON STOCK (PRVA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 48,014 $1,138,423 +$462,147 2,371% 7
2025 Q3 119,699,630 $2,980,447,755 +$56,454,820 2,490% 253
2025 Q2 117,676,432 $2,706,044,410 -$67,398,305 2,300% 280
2025 Q1 120,660,066 $2,708,784,802 +$26,046,917 2,245% 247
2024 Q4 120,039,386 $2,347,109,883 +$3,857,281 1,955% 229
2024 Q3 119,642,201 $2,178,054,609 +$17,338,786 1,821% 232
2024 Q2 118,046,264 $2,051,722,091 +$6,487,125 1,738% 227
2024 Q1 117,674,329 $2,305,180,930 +$9,079,193 1,959% 229
2023 Q4 5,295,339 $121,951,657 +$291,537 2,303% 2
2023 Q3 106,035,145 $2,438,617,090 +$24,622,066 2,300% 214
2023 Q2 104,310,315 $2,723,898,395 +$700,589,038 2,611% 229
2023 Q1 80,808,748 $2,231,051,469 +$11,763,383 2,761% 188
2022 Q4 80,873,677 $1,836,540,035 +$55,161,261 2,271% 189
2022 Q3 75,471,382 $2,570,423,481 +$143,060,195 3,406% 197
2022 Q2 69,763,550 $2,031,221,670 +$116,840,583 2,912% 146
2022 Q1 65,595,706 $1,752,843,229 +$92,082,803 2,672.97% 141
2021 Q4 61,682,840 $1,595,152,395 +$198,725,734 2,587% 114
2021 Q3 53,786,751 $1,267,742,214 -$80,681,384 2,356% 85
2021 Q2 56,839,812 $2,521,794,118 +$2,521,793,539 4,437.01% 88